abrdn Life Sciences Investors (HQL) To Go Ex-Dividend on August 24th

abrdn Life Sciences Investors (NYSE:HQL) announced a quarterly dividend on Tuesday, August 11th. Shareholders of record on Monday, August 24th will be paid a dividend of 0.62 per share on Wednesday, September 30th. This represents a c) dividend on an annualized basis and a yield of 11.1%. The ex-dividend date is Monday, August 24th.

abrdn Life Sciences Investors Price Performance

HQL opened at $22.38 on Friday. The company’s 50 day simple moving average is $19.89 and its 200-day simple moving average is $18.06. abrdn Life Sciences Investors has a one year low of $13.57 and a one year high of $22.67.

abrdn Life Sciences Investors Company Profile

abrdn Life Sciences Investors (NYSE: HQL) is a closed-end management investment company that seeks capital appreciation through investment in the life sciences sector. Established in 1994, the trust focuses on equity and equity-related securities of companies engaged in biotechnology, pharmaceuticals, medical devices, diagnostics and related fields. Its closed-end structure allows portfolio managers to maintain a stable pool of capital, pursue long-term investment strategies and employ leverage when deemed appropriate.

The fund’s portfolio spans both public and private companies, with an emphasis on businesses driving innovation in drug development, gene therapy, precision medicine and healthcare technology.